NG-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: Inhibition by angiotensin II type 1 receptor antagonism

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 3, 2002, Pages 478-486

  Suo, Maria ^a   Kalliovalkama, Jarkko ^a   Pörsti, Ilkka ^a   Jolma, Pasi ^a   Tolvanen, Jari Petteri ^a   Vuolteenaho, Olli ^a   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Angiotensin II; Blood pressure; Hypertrophy; Losartan; Natriuretic peptides; Nitric oxide

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; LOSARTAN; MESSENGER RNA; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HYPERTENSION; IMMUNOREACTIVITY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMAL; ATRIAL NATRIURETIC FACTOR; COMPARATIVE STUDY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HYPERTENSION; IN VITRO; LOSARTAN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; SUPPORT, NON-U.S. GOV'T; ANIMALS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 0036708268     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200209000-00017     Document Type: Article

References (41)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Nitric oxide synthase in cultured endocardial cells of the pig
3. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage
4. Angiotensin alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension
5. Long-term cardiovascular role of nitric oxide in conscious rats
6. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats
7. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats
8. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension: Novel molecular adaptation to systolic load in absence of hypertrophy
9. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats
10. Cardiac weight in hypertension induced by nitric oxide synthase blockade
11. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase
12. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade
13. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats
14. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension
15. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade
16. Renal and vascular effects of chronic nitric oxide synthase inhibition: Involvement of endothelin I and angiotensin II
17. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: Acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro
18. Modulation of mouse cardiac function in vivo by eNOS and ANP
19. Effects of nitric oxide synthesis inhibition on the atrial natriuretic peptide system
20. Blood pressure variability in established L-NAME hypertension in rats
21. Gene structure of a new cardiac peptide hormone: A model for heart- specific gene expression
22. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression
23. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion
24. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium: Effects of exercise
25. Reninangiotensin system involvement in pressure-overload cardiac hypertrophy in rats
26. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats
27. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat
28. Long-term cardiac effects on hypotensive agents in normotensive mature rats: Comparison of beta-blocking agent and converting enzyme inhibition
29. Molecular mechanisms of myocardial remodeling
30. Mechanical and neuroendocrine regulation of the endocrine heart
31. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthetized by fibroblasts infiltrating the infarct
32. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: Role of endothelin, nitric oxide, and angiotensin II
33. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rat with heart failure: Role of kinins and angiotensin II type 2 receptors
34. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
35. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production
36. Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat
37. Atrial natriuretic peptide: Synthesis, release and metabolism
38. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat
39. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: Role of renin and vascular hypertrophy
40. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase
41. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis